PT-141
$42.99
10mg
PT-141 (Bremelanotide) is a synthetic peptide studied for its activity as a melanocortin receptor agonist, particularly at MC3R and MC4R receptors. It has been investigated in clinical and research settings for its role in central nervous system signaling pathways involved in sexual arousal and related regulatory mechanisms.
Usage Disclaimer: Research Use Only. This product is intended strictly for laboratory research and in-vitro studies. It is not for human or animal consumption, medical use, or diagnostic purposes. Any unauthorized use of this product is strictly prohibited.
FDA Compliance: FDA Notice. The statements made regarding these products have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Research Studies
FDA Approval Trial for Hypoactive Sexual Desire Disorder (2019)
Human | 1.75mg subcutaneous | As needed | 24.5% improvement vs 17.2% placebo
Phase 3 trials in premenopausal women with HSDD showed statistically significant improvements in sexual desire and reduced distress related to low sexual desire.
Male Erectile Dysfunction Clinical Trial (2017)
Human | 1-20mg intranasal | Single dose | Dose-dependent erectile response
Clinical studies demonstrated PT-141 induced erections in men with ED, including those unresponsive to PDE5 inhibitors, through central nervous system pathways.
Mechanism of Action Study (2016)
In vitro + Animal | Various doses | Receptor binding assays
Research confirmed PT-141 selectively binds MC3R and MC4R receptors, activating neural pathways involved in sexual arousal without peripheral vasodilation.
Pair your peptide order with bacteriostatic water for proper reconstitution and storage. Adding it now ensures you have everything you need when your order arrives.
Avoid delays and complete your setup in one shipment.
